Seminars in Arthritis and Rheumatism
Volume 26, Issue 5 , Pages 713-723 , April 1997

A potential new treatment for rheumatoid arthritis:Thunder god vine

    MD
  • Peter E. Lipsky (Professor of Internal Medicine and Microbiology)

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Peter E. Lipsky, MD, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75235-8884.
    • , MD
  • Xue-Lien Tao (Instructor of Internal Medicine)

References 

  1. Jiang YS, Zhao S. Tripterygium wilfordii Hook induced acute toxicity with kidney involvement in 17 cases. Chin J Kidney Dis. 1987;3:167
  2. Chen LN, Cai H, Yu DY. Clinical analysis of 10 cases of Tripterygium wilfordii Hook induced toxicity. In: Proc Symp Clinical Application of Tripterygium wilfordii Hook. Hubei, China. 1987;
  3. Spence JD. The search for modern China. New York, NY: WW Norton; 1991;
  4. Zheng JR, Xu LF, Ma L. Clinical and experimental studies on Tripterygium. J Tradit Chin Med. 1982;23:714–718
  5. Zhang L, Zhang ZX, An DK. The achievements in the studies of chemical components of TWH family. J Chin Pharm Univ. 1990;21:251
  6. Xue ZY, Xue JH, Tang YC, et al. Treatment of 21 cases of systemic lupus erythematosus with Tripterygium wilfordii Hook f. Chin J Derm. 1981;7:201–202
  7. Cheng ZZ, Lin XQ, Lu P, et al. In: Proceedings in the study of the active compounds of tripterygium wilfordii Hook f. Zong Guo Yi Yaun Yao Xue Za Zhi. 6:1986;p. 26–28
  8. Cheng ZZ, Wan M. Study of the active compounds and the preparation of Tripterygium wilfordii Hook F. Zi Liao Hui Bian. 1988;10(11):6–9
  9. Lu X, Mao PC, Chen Y, et al. The isolation of the structure of triptochlorolide (T4) from Tripterygium wilfordii. Acta Academiae Medicinae Sinica. 1990;12:157–161
  10. Ma P, Lu XY, Yang JJ, et al. 16-hydroxytriptolide, a new active diterpene isolated from tripterygium wilfordii. Acta Pharmaceutica Sinica. 1991;26:759–763
  11. Cheng ZZ, Lin XQ, Wang LQ, et al. Quantitative measurement of triptolide content in the tablets of Tripterygium wilfordii Hook F. Zi Liao Hui Bian. 1985;2:212–213
  12. Guo XF, Wang XM, Li EJ. Quantitative measurement of triptolide contained in the ethyl acetate extract of tripterygium wilfordii Hook F and its tablets. Zhong Yao Tong Bao. 1986;11:486–488
  13. Tao XL, Cai JJ, Lipsky PE. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook f. J Pharm Exp Ther. 1995;272:1305–1312
  14. Xu WY, Zheng JR, Lu XY. Tripterygium in dermatologic therapy. Int J Derm. 1985;24:152–157
  15. Tripterygium Study Group, Institute of Dermatology. Total glycosides in Tripterygium wilfordii: Study of its therapeutic effect in certain dermatoses. Chin J Dermatol. 1982;15:199–203
  16. Wentang Worker's Sanatorium , Institute of Dermatology . Treatment of psoriasic arthritis with total glycosides in tripterygium: Symposium on experimental and clinical studies of the total glycosides inTripterygium wilfordii. In: Clinical Section. 1981;p. 143–152
  17. Long ZH, Yin ZY. Efficacy of the treatment of arthropathic psoriasis with Tripterygium wilfordii Hook f. Beijing Trad Med. 1983;1:2–3
  18. Tripterygium Study Group, Institute of Dermatology. Preliminary observation on some skin diseases treated with crude preparation of Tripterygium wilfordii. Common Res Prophylaxis Therap Dermatol. 1977;6:174–177
  19. Zheng JR. Observation on treatment of Behcet's disease and recurrent aphthous ulcers with total glycosides in tripterygium. In: Symposium on Experimental and Clinical Studies on the Total Glycosides in Tripterygium wilfordii, Clinical Section. 1981;p. 139–141
  20. Xie DE. Experience in the treatment of Behcet's disease with polyglycosides of Tripterygium wilfordii Hook f. Zong Xi Yi Jie He Za Zhi. 1983;3:349–350
  21. Qin WZ. Clinical observation on 26 cases of discoid LE treated by Tripterygium wilfordii. J Tradit Chin Med. 1982;23:179
  22. Department of Dermatology, Kunming Medical College . Clinical observation on 29 cases of lupus erythematosus treated by Tripterygium hypoglaucum (Lev1) Hutch. Common Res Prophylaxis Therap Dermatol. 1978;7:5
  23. Qin WZ, Yang SM, Zhu GD, et al. Treating 103 cases of SLE with Tripterygium wilfordii Hook f. Chin J Dermatol. 1982;15:141
  24. Liao WQ, Shao JZ. Clinical observation on the treatment of SLE with Tripterygium wilfordii Hook f. Commun Res Prophylaxis Ther Dermatol. 1980;9:14
  25. Xue ZY. Treatment of SLE with total glycosides in Tripterygium wilfordii. In: Symposium on Experimental and Clinical Studies of the Total Glycosides of Tripterygium wilfordii Hook f.. Clinical Section. 1981;p. 53–58
  26. Qin WZ, Yang SM, Zhu GD, et al. Tripterygium wilfordii Hook f in system lupus erythematosus: Report of 103 cases. Chin Med J. 1981;94:827–834
  27. Li XW. Treatment of nephrotic syndrome with total glycosides in Tripterygium wilfordii in children: Clinical observation of 53 cases. In: Symposium on Experimental and Clinical Studies of the Total Glycosides in Tripterygium wilfordii Hook f.. Chin Pediatr J. 20:1982;p. 203–204
  28. Li L. Treatment of glomerulonephritis with total glycosides of Tripterygium wilfordii: An analysis of 44 cases. In: Symposium on Experimental and Clinical Studies of the Total Glycosides in Tripterygium wilfordii Hook f.. Clinical Section. 1981;p. 83–87
  29. Peng SY, Guo SJ, Doug SR, et al. Treatment of Henoch-Schoenlein purpura with total glycosides of Tripterygium wilfordii. Jiangsu Med J. 1983;9:38
  30. Tripterygium Cooperative Research Group of Fujian and Jiangsu Provinces. Preliminary observation on tripterygium in treatment of lepra reactions. Commun Res Prophylaxis Ther Dermatol. 1974;3:219–224
  31. Institute of Dermatology . Observation of tripterygium in treatment of lepra reactions. Acta Acad Med Sinicae. 1979;1:71
  32. Feng B. Observation on therapeutic effect of total glycosides of tripterygium in 43 cases of lepra reactions. In: Symposium on Experimental and Clinical Studies of Total Glycosides of Tripterygium wilfordii. Clinical Section. 1981;p. 125–130
  33. Lei Gang Teng Cooperative Research Group of Fujian and Jiangsu Provinces. Clinical observation on chinese herb Lei Gong Teng in treatment of lepra reaction. Acta Academiae Medicinae Sinicae. 1979;1:71–74
  34. Tripterygium Research Group of Institute of Dermatology. Observation on total glycosides of Tripterygium wilfordii in treatment of some dermatoses. Acta Acad Med Sinicae. 1979;1:136–138
  35. Tao X, Sun Y, Dong Y, et al. A prospective, controlled, double-blind, cross-over study of Tripterygium wilfordii Hook F in treatment of rheumatoid arthritis. Chin Med J. 1989;102:327–332
  36. Tao XL, Dong Y, Zhang N-Z, et al. A double-blind controlled trial of Tripterygium wilfordii glycosides in rheumatoid arthritis. Arthritis Rheum. 1987;30:S59
  37. T2 study group of Jiang So, China. Summary on the clinical trials of T2 in the treatment of 554 patients with various diseases. Ann Chin Acad Med Sci. 1982;3:3
  38. Yu DY. Clinical observation of 144 cases of rheumatoid arthritis treated with glycoside of radix Tripterygium wilfordii. J Tradit Chin Med. 1983;3:125–129
  39. T2 study group of Chinese Institute of Dermatology. Clinical observation on the treatment of skin disorders with polyglycoside of Tripterygium wilfordii Hook F. Acta Acad Med Sinicae. 1979;1:6
  40. Xie DF. Experience in the treatment of Behcet's disease with polyglycosides of Tripterygium wilfordii Hook f. Zohg Xi Yi Jie He Za Zhi. 1983;3:349–350
  41. Feng B. Observation on the effect of polyglycosides of Tripterygium wilfordii Hook (T2) in 50 cases of leprosy reactive status. Clin Dermatol J. 1985;4:211
  42. Wu YZ. Treatment of neuralgia of leprosy reactive status with polyglycosides of Tripterygium wilfordii Hook f (T2). Chin J Dermatol. 1986;19:217–218
  43. Jiang XY. Exploration of the treatment of nephrotic syndrome with polyglycosides of Tripterygium wilfordii Hook f (T2). Chin J Pediatr. 1982;20:201
  44. Li XW. Clinical observation on the treatment of 53 cases of nephrotic syndrome with polyglycoside of Tripterygium wilfordii Hook f (T2). Chin J Pediatr. 1982;20:203–204
  45. Wang QW, Lie LS, Zhang JH, et al. Clinical investigation of treatment with Tripterygium wilfordii Hook f of idiopathic IgA nephropathy. Jian Su Yi Yao. 1991;1:7–9
  46. Li XW. Treatment of 50 cases of childhood purpura nephritis with polyglycosides of Tripterygium wilfordii Hook f (Clinical observation). Jiang Su Yi Yao. 1987;12:662–665
  47. Pan YR. Treatment of purpura nephritis with Tripterygium wilfordii Hook f. Acta Acad Med Sinicae. 1987;9:2–4
  48. Cheng RL. Observation of the therapeutic effect of polyglycosides of Tripterygium wilfordii Hook (T2) combined with thyroid gland tablets on chronic lymphocytic thyroiditis. Zhong Xi Yi Re He Za Zhi. 1988;8:676
  49. Hubei Cooperative Study Group of Tripterygium wilfordii Hook. Clinical study of the extract of Tripterygium wilfordii hook in the treatment of rheumatoid arthritis. Wu Han Yi Xue Yuan Xue Bao. 1981;4:62–66
  50. Shu DF, Li RL, Sun YJ. Report of 270 cases of rheumatoid arthritis treated with ethyl acetate extract of tripterygium wilfordii Hook. Zhong Yao Li Yu Lin Chuang. 1989;5:40–42
  51. Kupchan SM, Court WA, Dailey RG, et al. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J Am Chem Soc. 1972;94:7194
  52. Kupchan SM, Schubert RM. Selective alkylation: A biomimetic reaction of the antileukemic triptolides?. Science. 1974;185:791–793
  53. Shu DF, Li RL, Sun YJ. Comparative study of triptolide and the ethyl acetate extract of Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis. Zhong Cao Yao. 1990;10:144–146
  54. Shu SY. Preliminary study of the treatment of rheumatoid arthritis with wilforne. Zhong Cao Yao. 1980;11:33
  55. Li LZ, Chen SF, Wang FJ, et al. Pharmacological study of the ethyl acetate extract of Tripterygium wilfordii Hook f. Zhong Cao Yao. 1982;13:27–32
  56. Hubei Cooperative Study Group of Tripterygium wilfordii Hook. Preliminary study on the pharmacological effect of Huangteng. Hubei Wei Sheng. 1979;1:72
  57. Zhang BH, Wang LY, Zheng EZ, et al. Study on the pharmacological action of total alkaloids in Tripterygium hypoglaucum Hutch. Zhong Cai Yao. 1985;16:360–363
  58. Zheng JR, Xu LF, Ma L, et al. Studies on pharmacological actions of total glycosides in Tripterygium wilfordii Hook. Acta Acad Med Sinicae. 1983;5:1–7
  59. Li LZ, Chen SF, Wang FJ, et al. Effect of triptolide on inflammation and immune function. Zhong Guo Yao Li Xue Tong Bao. 1986;2:25–28
  60. Zheng YL, Ye JR, Yu HS, et al. Effect of Tripterygium wilfordii Hook decoction and its effective fraction on immune functions. Fujian Yi Yao Za Zhi. 1982;4:222–224
  61. Qian QF, Gao YX. Experimental study of the effect of Tripterygium wilfordii Hook on allergic and toxic contact dermatitis. Chin J Dermatol. 1985;18:2–5
  62. Zhao P, Huang XC, Du HW, et al. Prolonged servival of syngeneic heart graft in mice by treatment with Tripterygium wilfordii Hook. Zhong Xi Yi Jie He Za Zhi. 1988;8:31–33
  63. Chang JL, Zhang XL, Guo J, et al. A preliminary study on the immunosuppressive activity of mixed glycoside of TWH. Chin J Micro Immunol. 1984;4:331–334
  64. Gu WZ, Brandwein SR, Banerjee S. Inhibition of type II collagen-induced arthritis in mice by an immunosuppressive extract of Tripterygium wilfordii Hook f. J Rheumatol. 1992;19:682–688
  65. Gu WZ, Brandwein SR. Triptolide inhibits type II collagen-induced arthritis in rats. Arthritis Rheum. 1994;38:S399
  66. Cheng HW. Cellular immunological study on experimental allergic encephalopathy and the exploration of the effect of Tripterygium wilfordii Hook on it. Immunol Bull. 1985;5:7
  67. Zhang XY, Tsuchiya N, Dohi M, et al. Prolonged survival of MRL-Ipr/Ipr mice treated with Tripterygium wilfordii Hook F. Clin Immun Immunopathol. 1992;62:66
  68. Gu WZ, Banerjee S, Brandwein SR, et al. Suppression of renal disease and arthritis, and prolongation of survival in MRL Ipr mice treated with an extract of Tripterygium wilfordii Hook F. Arthritis Rheum. 1992;35:1381
  69. Zuo DM, Shang SL. Different effect of Tripterygium reglii on T and B cell function. Chin J Immunol. 1986;2:232–235
  70. Zhang LS, Gu KX, Cao ZF, et al. Inhibitory effect of celastrol on murine lymphocyte proliferation. Acta Pharmacol Sinicae. 1986;7:85–87
  71. Kuang YD, Zhang H, Qing WZ. Effect of TWH on IL-2 production and IL-2 receptor expression. Shanghai J Immunol. 1988;8:250
  72. Zhu XY, Shi Y, Fei SJ. In vitro observation on the effect of Tripterygium hypoglaucum hutch on immune responses. Physiol Sci. 1988;8:417
  73. Tao XL, Davis LS, Lipsky PE. Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness. Arthritis Rheum. 1991;34:1274–1281
  74. Li XW, Weir MR. Radix Tripterygium wilfordii: A Chinese herbal medicine with potent immunosuppressive properties. Transplant. 1990;50:82–86
  75. Tao XL, Davis LS, Lipsky PE, et al. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction. J Pharm Exp Ther. 1996;276:316–325
  76. Zhang YP, Xing SL. An experimental pathological study of intoxication by the ethyl acetate extract of Lei Gong Teng (Tripterygium wilfordii Hook F). Yao Wu Yan Jiu. 1983;4:367
  77. Wang ZF, Zhang YH, Huang GZ. An experimental pathological study of subchronic toxicity by ethyl acetate extract of tripterygium wilfordii Hook. Tong Ji Ti Ke Da Xue Bao. 1991;20:247
  78. Zheng JR, Liu JH, Xu LF, et al. Studies on toxicity of total glycosides in Tripterygium wilfordii. Acta Acad Med Sinicae. 1983;5:73–78
  79. Zheng JR, Fang JL, Xu LF, et al. Effect of total glycosides of Tripterygium wilfordii on animal reproductive organs. 1. Experiments of male rats. Acta Acad Med Sinicae. 1985;7:1–5
  80. Zheng JR, Fang JL, Xu LF, et al. Effects of total glycosides of Tripterygium wilfordii on reproductive organs of experimental animals. II. Experiments in female rats. Acta Acad Med Sinicae. 1985;7:256–259
  81. Ropes MW, Bennett GA, Cobb S, et al. Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958;9:175–176

* Supported by the Harold C. Simmons Arthritis ResearchCenter, Southwestern Medical Center, Dallas, TX.

PII: S0049-0172(97)80040-6

Seminars in Arthritis and Rheumatism
Volume 26, Issue 5 , Pages 713-723 , April 1997

Article Tools